• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL (BD WEST) MEDICAL SURGICAL 3 ML BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGE, 30 USP UNITS/3 ML; PREFILLED HEPARIN FLUSH SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL (BD WEST) MEDICAL SURGICAL 3 ML BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGE, 30 USP UNITS/3 ML; PREFILLED HEPARIN FLUSH SYRINGE Back to Search Results
Catalog Number 306413
Device Problem Microbial Contamination of Device (2303)
Patient Problems Cardiac Arrest (1762); Death (1802)
Event Date 08/24/2018
Event Type  Death  
Manufacturer Narrative
No samples were provided for evaluation.There was no documentation of issues for the complaint of this batch # during this production run.All our inspections performed while manufacturing this batch # was accepted; no rejections were documented.Controls in place at the manufacturing site: - bioburden tested on a weekly basis.- an overkill sterilization process is used.- environmental testing within the filling area is done on a biweekly basis.- the sterilization process is challenged and re-qualified annually.- the solution is filtered twice before it is filled in syringes (note: once when transferring to the hold tank and again at the fill machine).- endotoxin testing is performed on each batch.- fill room operators are trained and qualified on gowning for the fill room environment on an annual basis.- weekly bioburden testing on the components used to assemble the syringes.- continuous online monitoring of the wfi (water for injection) water quality (note: this is for toc (total organic carbon) and conductivity, not microbial.- weekly bioburden and endotoxin testing of the (b)(4) purified water and wfi systems.- weekly endotoxin testing of the pure steam system.- each sterilizer is thoroughly validated before use for posiflush sterilization.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Investigation conclusion: this is the first complaint for lot # 814601n for this type of defect or symptom.There was no documentation of issues for the complaint of batch # 814601n during this production run.Root cause description: undetermined.
 
Event Description
A patient's son reported that his father passed away on (b)(6) 2018.The cause of death was reported as a heart attack related to a blood clot.The patient also had a history of septic shock, (b)(6) from gangrene in (b)(6) and (b)(6), a partial foot amputation, a heart attack three months prior to his death with one stent placed in his left leg and two stents placed in his heart, and was hospitalized for one month.The patient's son indicated that these events occurred while the patient was using a 3 ml bd posiflush¿ heparin lock flush syringe, 30 usp units/3 ml (10 usp units/ml).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3 ML BD POSIFLUSH¿ HEPARIN LOCK FLUSH SYRINGE, 30 USP UNITS/3 ML
Type of Device
PREFILLED HEPARIN FLUSH SYRINGE
Manufacturer (Section D)
BD MEDICAL (BD WEST) MEDICAL SURGICAL
1852 10th avenue
columbus NE 68601
Manufacturer (Section G)
BD MEDICAL (BD WEST) MEDICAL SURGICAL
1852 10th avenue
columbus NE 68601
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key7866934
MDR Text Key119922974
Report Number1911916-2018-00530
Device Sequence Number1
Product Code NZW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date11/30/2019
Device Catalogue Number306413
Device Lot Number814601N
Was Device Available for Evaluation? No
Date Manufacturer Received08/24/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/25/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
-
-